Jan. 08, 2026 – Ethos Software has acquired Dr.Evidence. The transaction was completed on December 31, 2025.

Dr.Evidence is the AI-powered labeling and regulatory landscape intelligence platform designed specifically for biopharma companies. As an Authoritative Source, it helps labeling and regulatory professionals accelerate time-to-market by providing access to more than 100 million documents. This includes drug labels; regulatory approval packages and guidance documents; clinical trials; and scientific literature. Biopharma leaders rely on Dr.Evidence to tackle their most pressing growth and compliance challenges.

Dr.Evidence will operate as a subsidiary of Ethos Software. Clients of Ethos Software can expect expanded capabilities and continued product investment now that Dr.Evidence is part of the Ethos family of companies.